185 related articles for article (PubMed ID: 34485165)
1. Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies.
Cao J; Zhang M; Wang B; Zhang L; Zhou F; Fang M
Front Oncol; 2021; 11():745052. PubMed ID: 34485165
[TBL] [Abstract][Full Text] [Related]
2. Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies.
Cao J; Zhang M; Wang B; Zhang L; Fang M; Zhou F
Front Oncol; 2021; 11():658552. PubMed ID: 34277408
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum: Discovery of Novel and Clinically Relevant Markers in Formalin-Fixed Paraffin-Embedded Esophageal Cancer Specimen.
Abdo J; Wichman CS; Dietz NE; Ciborowski P; Fleegel J; Mittal SK; Agrawal DK
Front Oncol; 2019; 9():273. PubMed ID: 31032230
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy.
Haritha NH; Nawab A; Vijayakurup V; Anto NP; Liju VB; Alex VV; Amrutha AN; Aiswarya SU; Swetha M; Vinod BS; Sundaram S; Guijarro MV; Herlevich T; Krishna A; Nestory NK; Bava SV; Sadasivan C; Zajac-Kaye M; Anto RJ
Front Oncol; 2023; 13():1302413. PubMed ID: 38162481
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: Sperm Protein Antigen 17 Expression Correlates With Lymph Node Metastasis and Worse Overall Survival in Patients With Breast Cancer.
Zhou YT; Qiu JJ; Wang Y; Liu PC; Lv Q; Du ZG
Front Oncol; 2020; 10():1003. PubMed ID: 32670882
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer.
Tian X; Wu L; Jiang M; Zhang Z; Wu R; Miao J; Liu C; Gao S
Front Oncol; 2022; 12():793448. PubMed ID: 35463385
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer.
Zhou Y; Zhang Q; Wang M; Huang C; Yao X
Front Oncol; 2022; 12():916983. PubMed ID: 35837110
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum: Carnosol, a natural polyphenol, inhibits migration, metastasis, and tumor growth of breast cancer via a ROS-dependent proteasome degradation of STAT3.
Alsamri H; Hasasna HE; Dhaheri YA; Eid AH; Attoub S; Iratni R
Front Oncol; 2023; 13():1235201. PubMed ID: 38486934
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum: Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein.
Nunes M; Silva PMA; Coelho R; Pinto C; Resende A; Bousbaa H; Almeida GM; Ricardo S
Front Oncol; 2022; 12():853608. PubMed ID: 35186774
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum: The NFAT3/RERG complex in luminal breast cancers is required to inhibit cell invasion and may be correlated with an absence of axillary lymph nodes colonization.
Coillard L; Guaddachi F; Ralu M; Brabencova E; Garbar C; Bensussan A; Le Bras M; Lehmann-Che J; Jauliac S
Front Oncol; 2022; 12():1016189. PubMed ID: 36110951
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum: Genomic Assays in Node Positive Breast Cancer Patients: A Review.
Bou Zerdan M; Ibrahim M; El Nakib C; Hajjar R; Assi HI
Front Oncol; 2021; 11():686355. PubMed ID: 33937090
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum: A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells.
Huang SS; Liao WY; Hsu CC; Chan TS; Liao TY; Yang PM; Chen LT; Sung SY; Tsai KK
Front Oncol; 2021; 11():718849. PubMed ID: 34239806
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum: Hepatic Steatosis Predicts Higher Incidence of Recurrence in Colorectal Cancer Liver Metastasis Patients.
Chen H; Dai S; Fang Y; Chen L; Jiang K; Wei Q; Ding K
Front Oncol; 2021; 11():742987. PubMed ID: 34490128
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum: E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer
Li J; Zhang W; Gao J; Du M; Li H; Li M; Cong H; Fang Y; Liang Y; Zhao D; Xiang G; Ma X; Yao M; Tu H; Gan Y
Front Oncol; 2021; 11():693855. PubMed ID: 34046366
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.
Li B; Zhao X; Zhang L; Cheng W
Front Oncol; 2021; 11():687841. PubMed ID: 34150656
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum: Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer.
Zheng Y; Zhong G; Yu K; Lei K; Yang Q
Front Oncol; 2020; 10():482. PubMed ID: 32328463
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: Combinatorial Strategies to Target Molecularand Signaling Pathways to Disarm Cancer Stem Cells.
Catara G; Colanzi A; Spano D
Front Oncol; 2021; 11():749040. PubMed ID: 34485166
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum: RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer.
Tan S; Yi P; Wang H; Xia L; Han Y; Wang H; Zeng B; Tang L; Pan Q; Tian Y; Rao S; Oyang L; Liang J; Lin J; Su M; Shi Y; Liao Q; Zhou Y
Front Oncol; 2020; 10():1106. PubMed ID: 32760669
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1.
Li Z; Chen C; Chen L; Hu D; Yang X; Zhuo W; Chen Y; Yang J; Zhou Y; Mao M; Zhang X; Xu L; Ju S; Shen J; Wang Q; Dong M; Xie S; Wei Q; Jia Y; Zhou J; Wang L
Front Oncol; 2022; 12():880458. PubMed ID: 35356217
[TBL] [Abstract][Full Text] [Related]
20. Erratum: The Deubiquitinating Enzyme UCHL1 Induces Resistance to Doxorubicin in HER2+ Breast Cancer by Promoting Free Fatty Acid Synthesis.
Frontiers Production Office
Front Oncol; 2021; 11():687249. PubMed ID: 33937091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
